Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Labate

Showing results (191-200 of 216) with videos related to

Pageof 22
Sort By:
JAMA Network Open|March 10, 2025
Second-Line Medications for Women Aged 10 to 50 Years With Idiopathic Generalized EpilepsyEmanuele Cerulli Irelli, Enrico Cocchi, Joanna Gesche, et al.
Neurology and Therapy|November 20, 2025
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar EfficacyRoberta Roberti, Cristina Politi, Francesca Anzellotti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 12, 2020
Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic reviewGiovanni Assenza, Mario Tombini, Jacopo Lanzone, et al.
Epilepsia|December 5, 2023
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE studyRoberta Roberti, Gianfranco Di Gennaro, Francesca Anzellotti, et al.
American Journal of Human Genetics|April 2, 2021
Progressive myoclonus epilepsies-Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genesCarolina Courage, Karen L Oliver, Eon Joo Park, et al.
Seizure|April 27, 2023
A retrospective multicentric study on the effectiveness of intravenous brivaracetam in seizure clusters: Data from the Italian experienceNiccolò Orlandi, Giuseppe d'Orsi, Giada Pauletto, et al.
Epilepsia|March 15, 2025
Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS studySimona Lattanzi, Fedele Dono, Giuseppe d'Orsi, et al.
Neuroimage. Clinical|August 2, 2021
Artificial intelligence for classification of temporal lobe epilepsy with ROI-level MRI data: A worldwide ENIGMA-Epilepsy studyEzequiel Gleichgerrcht, Brent C Munsell, Saud Alhusaini, et al.
Epilepsia|November 30, 2021
Atlas of lesion locations and postsurgical seizure freedom in focal cortical dysplasia: A MELD studyKonrad Wagstyl, Kirstie Whitaker, Armin Raznahan, et al.
Science Advances|November 19, 2020
Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA studySara Larivière, Raúl Rodríguez-Cruces, Jessica Royer, et al.
Pageof 22

Showing results (191-200 of 216) with videos related to

Sort By:
Pageof 22
JAMA Network Open|March 10, 2025
Second-Line Medications for Women Aged 10 to 50 Years With Idiopathic Generalized EpilepsyEmanuele Cerulli Irelli, Enrico Cocchi, Joanna Gesche, et al.
Neurology and Therapy|November 20, 2025
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar EfficacyRoberta Roberti, Cristina Politi, Francesca Anzellotti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 12, 2020
Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic reviewGiovanni Assenza, Mario Tombini, Jacopo Lanzone, et al.
Epilepsia|December 5, 2023
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE studyRoberta Roberti, Gianfranco Di Gennaro, Francesca Anzellotti, et al.
American Journal of Human Genetics|April 2, 2021
Progressive myoclonus epilepsies-Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genesCarolina Courage, Karen L Oliver, Eon Joo Park, et al.
Seizure|April 27, 2023
A retrospective multicentric study on the effectiveness of intravenous brivaracetam in seizure clusters: Data from the Italian experienceNiccolò Orlandi, Giuseppe d'Orsi, Giada Pauletto, et al.
Epilepsia|March 15, 2025
Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS studySimona Lattanzi, Fedele Dono, Giuseppe d'Orsi, et al.
Neuroimage. Clinical|August 2, 2021
Artificial intelligence for classification of temporal lobe epilepsy with ROI-level MRI data: A worldwide ENIGMA-Epilepsy studyEzequiel Gleichgerrcht, Brent C Munsell, Saud Alhusaini, et al.
Epilepsia|November 30, 2021
Atlas of lesion locations and postsurgical seizure freedom in focal cortical dysplasia: A MELD studyKonrad Wagstyl, Kirstie Whitaker, Armin Raznahan, et al.
Science Advances|November 19, 2020
Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA studySara Larivière, Raúl Rodríguez-Cruces, Jessica Royer, et al.
Pageof 22